BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24383119)

  • 1. Transcatheter closure of patent foramen ovale does not reduce the risk of recurrent ischemic stroke versus medical therapy alone: a meta-analysis of randomized controlled trials.
    Zhang B; Zhou J; Li H; Zhou M; Chen A; Zhao Q
    Int J Cardiol; 2013 Nov; 169(6):e106-8. PubMed ID: 24383119
    [No Abstract]   [Full Text] [Related]  

  • 2. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
    Khan AR; Bin Abdulhak AA; Sheikh MA; Khan S; Erwin PJ; Tleyjeh I; Khuder S; Eltahawy EA
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1316-23. PubMed ID: 24139929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.
    Rengifo-Moreno P; Palacios IF; Junpaparp P; Witzke CF; Morris DL; Romero-Corral A
    Eur Heart J; 2013 Nov; 34(43):3342-52. PubMed ID: 23847132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM; Carroll JD
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent Foramen Ovale Closure Versus Medical Therapy in Cryptogenic Strokes and Transient Ischemic Attacks: A Meta-Analysis of Randomized Trials.
    Vidale S; Russo F; Campana C; Agostoni E
    Angiology; 2019 Apr; 70(4):325-331. PubMed ID: 30270651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review.
    Saver JL; Mattle HP; Thaler D
    Stroke; 2018 Jun; 49(6):1541-1548. PubMed ID: 29760277
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Akobeng AK; Abdelgadir I; Boudjemline Y; Hijazi ZM
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):165-173. PubMed ID: 29602258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events.
    Pineda AM; Nascimento FO; Yang SC; Kirtane AJ; Sommer RJ; Beohar N
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):968-75. PubMed ID: 23832613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.
    Kasner SE; Thomassen L; Søndergaard L; Rhodes JF; Larsen CC; Jacobson J
    Int J Stroke; 2017 Dec; 12(9):998-1004. PubMed ID: 29090661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis.
    Almekhlafi MA; Wilton SB; Rabi DM; Ghali WA; Lorenzetti DL; Hill MD
    Neurology; 2009 Jul; 73(2):89-97. PubMed ID: 19439720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials.
    Schulze V; Lin Y; Karathanos A; Brockmeyer M; Zeus T; Polzin A; Perings S; Kelm M; Wolff G
    Clin Res Cardiol; 2018 Sep; 107(9):745-755. PubMed ID: 29500568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.
    Abdelaziz HK; Saad M; Abuomara HZ; Nairooz R; Pothineni NVK; Madmani ME; Roberts DH; Mahmud E
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):176-186. PubMed ID: 29726616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Stroke After Transcatheter Patent Foramen Ovale Closure: A Systematic Review and Meta-analysis.
    Alvarez C; Siddiqui WJ; Aggarwal S; Hasni SF; Hankins S; Eisen H
    Am J Med Sci; 2018 Aug; 356(2):103-113. PubMed ID: 30219151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter patent foramen ovale closure versus standard medical therapy for prevention of recurrent stroke: Updated Meta-analysis with an importance on shunt size.
    Patel K; Doshi R; Goyal H; Shah P; Meraj P
    Eur J Intern Med; 2018 Nov; 57():e31-e33. PubMed ID: 30146180
    [No Abstract]   [Full Text] [Related]  

  • 17. Patent foramen ovale and cryptogenic stroke: the hole story.
    Furlan AJ; Jauss M
    Stroke; 2013 Sep; 44(9):2676-8. PubMed ID: 23908069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials.
    Nagaraja V; Raval J; Eslick GD; Burgess D; Denniss AR
    Heart Lung Circ; 2013 Nov; 22(11):903-9. PubMed ID: 24035325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Stroke: Meta-Analysis of Randomised Trials.
    Wang TKM; Wang MTM; Ruygrok P
    Heart Lung Circ; 2019 Apr; 28(4):623-631. PubMed ID: 29602754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
    Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Marco Bonifati D; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Tomelleri G; Spalloni A; Giorli E; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Piras V; Rasura M; Simone AM; Gamba M; Cerrato P; Zedde ML; Micieli G; Melis M; Massucco D; Guido D; De Giuli V; Bonaiti S; D'Amore C; La Starza S; Iacoviello L; Padovani A;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.